Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

© 2026 Go Backs. All rights reserved.

Medium RiskFDA Drug
Medications & Supplements/Prescription Drugs

Alkermes Inc: Vivitrol Injection Kits Recalled Due to Incorrect Needle Size in Packaging

Agency Publication Date: August 29, 2019
Share:
Sign in to monitor this recall

Summary

Alkermes Inc. is recalling 6,514 units of Vivitrol (naltrexone for extended-release injectable suspension) 380 mg/vial kits. The recall was initiated because 1-inch needles were accidentally placed inside cardboard sleeves labeled as 1.5-inch administration needles. While the medication vial itself is not impacted, using the incorrect needle length may affect the proper administration of the medication. These prescription kits were distributed nationwide across the United States.

Risk

The use of a shorter 1-inch needle when a 1.5-inch needle is required may result in the medication being injected into the wrong tissue layer, potentially affecting how the drug is absorbed or causing local injection site reactions.

What You Should Do

  1. Check your Vivitrol (naltrexone) 380 mg/vial kit for Lot Number 2018-3010T with an expiration date of 8/2021 and Kit NDC 65757-300-01.
  2. Open the kit and inspect the cardboard sleeves labeled for 'administration needles' to verify if the needle inside matches the 1.5-inch length described on the sleeve.
  3. Contact your healthcare provider or pharmacist immediately for guidance if you find the incorrect needle size or if you have already used a kit from this lot.
  4. Return any unused product kits from Lot 2018-3010T to your pharmacy for a refund and to obtain a replacement with the correct components.
  5. Contact Alkermes Inc. directly if you have further questions regarding this recall or need assistance with the return process.
  6. Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls for additional information.

Your Remedy Options

💰Full Refund

Healthcare provider consultation and pharmacy return

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund

Affected Products

Product: Vivitrol (naltrexone for extended-release injectable suspension) 380 mg/vial Kit
Model:
NDC 65757-300-01
Recall #: D-1846-2019
Lot Numbers:
2018-3010T (Exp 8/2021)
Date Ranges: Expiration Date: 8/2021

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 83511
Status: Resolved
Manufacturer: Alkermes Inc
Sold By: Pharmacies
Manufactured In: United States
Units Affected: 6,514 kits
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.